NLTX logo

Neoleukin Therapeutics (NLTX) Total Debt

Annual Total Debt

$12.07 M
-$914.00 K-7.04%

December 31, 2022


Summary


Performance

NLTX Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNLTXbalance sheetmetrics:

Quarterly Total Debt

$10.69 M
-$349.00 K-3.16%

September 30, 2023


Summary


Performance

NLTX Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNLTXbalance sheetmetrics:

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

NLTX Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-7.0%-11.4%
3 y3 years+896.7%-9.6%
5 y5 years+10000.0%+10000.0%

NLTX Total Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-7.0%at low-17.6%at low
5 y5-year-7.0%-90.0%-22.7%-88.7%
alltimeall time-7.0%-100.0%-22.7%-100.0%

Neoleukin Therapeutics Total Debt History

DateAnnualQuarterly
Sep 2023
-
$10.69 M(-3.2%)
Jun 2023
-
$11.04 M(-5.5%)
Mar 2023
-
$11.68 M(-3.2%)
Dec 2022
$12.07 M(-7.0%)
$12.07 M(-0.0%)
Sep 2022
-
$12.07 M(-2.9%)
Jun 2022
-
$12.43 M(-2.2%)
Mar 2022
-
$12.71 M(-2.1%)
Dec 2021
$12.98 M(+7.1%)
$12.98 M(-2.3%)
Sep 2021
-
$13.29 M(-1.9%)
Jun 2021
-
$13.54 M(-2.0%)
Mar 2021
-
$13.83 M(+14.1%)
Dec 2020
$12.12 M(+901.0%)
$12.12 M(+2.5%)
Sep 2020
-
$11.83 M(+11.5%)
Jun 2020
-
$10.61 M(-2.9%)
Mar 2020
-
$10.93 M(+802.4%)
Dec 2019
$1.21 M(+7973.3%)
$1.21 M(+96.6%)
Sep 2019
-
$616.00 K(+35.1%)
Jun 2019
-
$456.00 K(-8.1%)
Mar 2019
-
$496.00 K(+3206.7%)
Dec 2018
$15.00 K
$15.00 K(+50.0%)
Sep 2018
-
$10.00 K(-58.3%)
Jun 2018
-
$24.00 K(-14.3%)
DateAnnualQuarterly
Mar 2018
-
$28.00 K(-15.2%)
Dec 2017
$33.00 K(-29.8%)
$33.00 K(-10.8%)
Sep 2017
-
$37.00 K(-7.5%)
Jun 2017
-
$40.00 K(-9.1%)
Mar 2017
-
$44.00 K(-6.4%)
Dec 2016
$47.00 K(+571.4%)
$47.00 K(+80.8%)
Sep 2016
-
$26.00 K(+271.4%)
Jun 2016
-
$7000.00(0.0%)
Mar 2016
-
$7000.00(0.0%)
Dec 2015
$7000.00(>+9900.0%)
$7000.00(>+9900.0%)
Sep 2015
-
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
$0.00(-100.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(-100.0%)
Dec 2013
$2.29 M(>+9900.0%)
$2.29 M(>+9900.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00
Dec 2012
$0.00
-

FAQ

  • What is Neoleukin Therapeutics annual total debt?
  • What is the all time high annual total debt for Neoleukin Therapeutics?
  • What is Neoleukin Therapeutics annual total debt year-on-year change?
  • What is Neoleukin Therapeutics quarterly total debt?
  • What is the all time high quarterly total debt for Neoleukin Therapeutics?
  • What is Neoleukin Therapeutics quarterly total debt year-on-year change?

What is Neoleukin Therapeutics annual total debt?

The current annual total debt of NLTX is $12.07 M

What is the all time high annual total debt for Neoleukin Therapeutics?

Neoleukin Therapeutics all-time high annual total debt is $12.98 M

What is Neoleukin Therapeutics annual total debt year-on-year change?

Over the past year, NLTX annual total debt has changed by -$914.00 K (-7.04%)

What is Neoleukin Therapeutics quarterly total debt?

The current quarterly total debt of NLTX is $10.69 M

What is the all time high quarterly total debt for Neoleukin Therapeutics?

Neoleukin Therapeutics all-time high quarterly total debt is $13.83 M

What is Neoleukin Therapeutics quarterly total debt year-on-year change?

Over the past year, NLTX quarterly total debt has changed by -$1.38 M (-11.42%)